2021-01-11,All You Need to Know About Adverum Biotechnologies (ADVM) Rating Upgrade to Buy
2021-01-11,Adverum Biotechnologies Completes Patient Enrollment for INFINITY Phase 2 Trial of ADVM-022 in DME and Provides 2021 Business Outlook
2021-01-08,Implied Volatility Surging for Adverum Biotechnologies (ADVM) Stock Options
2021-01-07,Adverum Biotechnologies Announces New GMP Gene Therapy Manufacturing Facility
2021-01-05,Adverum Biotechnologies to Present at 39th Annual J.P. Morgan  Healthcare Conference
2020-12-21,Is ADVM A Good Stock To Buy According To Hedge Funds?
2020-12-14,Adverum Biotechnologies Appoints Pharmaceutical Industry Veteran Dawn Svoronos to Board of Directors
2020-11-23,Adverum Biotechnologies Presents at the Piper Sandler Annual Virtual Healthcare Conference
2020-11-14,Adverum Biotechnologies Announces Positive Interim Data from Cohorts 1-4 from OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD
2020-11-08,We're Hopeful That Adverum Biotechnologies (NASDAQ:ADVM) Will Use Its Cash Wisely
2020-11-05,"Adverum Biotechnologies (ADVM) Reports Q3 Loss, Misses Revenue Estimates"
2020-11-05,Adverum Biotechnologies Reports Recent Business Progress and Third Quarter 2020 Financial Results
2020-10-20,Adverum Biotechnologies to Present New Data from the OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at AAO 2020 Virtual
2020-10-09,Is the Options Market Predicting a Spike in Adverum Biotechnologies (ADVM) Stock?
2020-09-29,"Adverum Biotechnologies, Inc. (ADVM) Is Stalling With Hedge Funds"
2020-09-15,"Adverum Biotechnologies Announces Appointment of Christopher J. Morrison, Ph.D. as Vice President, Process Science"
2020-09-10,Adverum Biotechnologies to Participate in the Cantor Virtual Global Healthcare Conference
2020-09-08,New Strong Sell Stocks for September 8th
2020-08-20,"Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Insiders Increased Their Holdings"
2020-08-18,Adverum Biotechnologies Announces Closing of $217 Million Public Offering of Common Stock
2020-08-17,Adverum (ADVM) Surges: Stock Moves 6.2% Higher
2020-08-12,Adverum Biotechnologies Announces Pricing of Public Offering of Common Stock
2020-08-11,Adverum Biotechnologies Announces $200 Million Public Offering of Common Stock
2020-08-11,"Adverum Biotechnologies, Inc. (ADVM) Q2 2020 Earnings Call Transcript"
2020-08-10,"Adverum Biotechnologies (ADVM) Reports Q2 Loss, Lags Revenue Estimates"
2020-08-10,"Adverum Biotechnologies Announces Positive Interim Data from Cohorts 1-4 from OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for wet AMD, Reports Recent Business Progress and Second Quarter 2020 Financial Results"
2020-07-29,Adverum Biotechnologies to Host a Conference Call and Webcast to Report Second Quarter 2020 Financial Results and Provide Corporate Update
2020-07-21,"Adverum Biotechnologies Announces Appointment of Thomas Kochy as Vice President, Commercial and Program Strategy"
2020-07-20,"Did Hedge Funds Make The Right Call On Adverum Biotechnologies, Inc. (ADVM) ?"
2020-07-13,Adverum Biotechnologies Announces First Patient Randomized in Phase 2 INFINITY Trial of ADVM-022 Single Injection Gene Therapy for Diabetic Macular Edema (DME)
2020-07-06,Adverum Biotechnologies Announces Completion of Patient Dosing in Cohort 4 of the OPTIC Phase 1 Trial of ADVM-022 Single Injection Gene Therapy for Wet AMD
2020-06-30,Edited Transcript of ADVM earnings conference call or presentation 28-May-20 8:30pm GMT
2020-06-25,Adverum Biotechnologies Announces Appointment of Heikki Jouttijärvi as Vice President of Manufacturing
2020-06-16,"The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO"
2020-06-15,Adverum Biotechnologies Announces Leadership Transition
2020-06-15,"Hedge Funds Are Betting On Adverum Biotechnologies, Inc. (ADVM)"
2020-06-04,Adverum Biotechnologies to Participate in Goldman Sachs 41st Annual Global Healthcare Conference
2020-05-29,"Adverum Biotechnologies, Inc. (ADVM) Q1 2020 Earnings Call Transcript"
2020-05-28,"Adverum Biotechnologies (ADVM) Reports Q1 Loss, Lags Revenue Estimates"
2020-05-28,"Adverum Biotechnologies Announces New INFINITY Phase 2 Trial for ADVM-022 in Diabetic Macular Edema, Reports Recent Business Progress and First Quarter 2020 Financial Results"
2020-05-28,"Adverum Biotechnologies, Inc. to Host Earnings Call"
2020-05-25,Has Adverum Biotechnologies (ADVM) Outpaced Other Medical Stocks This Year?
2020-05-21,Adverum Biotechnologies to Host a Conference Call and Webcast to Report First Quarter 2020 Financial Results and Provide Corporate Update
2020-05-09,3 Best Healthcare Stocks to Buy in May
2020-05-07,Is Adverum Biotechnologies (ADVM) Outperforming Other Medical Stocks This Year?
2020-05-06,Here's Why Adverum Biotechnologies Is Soaring Today
2020-05-05,Small Biotech Rockets To 5-Year High On Regeneron-Rivaling Gene Therapy
2020-05-05,Why Adverum Biotechnologies Stock Is Soaring Today
2020-05-05,"The Daily Biotech Pulse: Bio-Rad's Coronavirus Test Gets EUA, Beat-And-Raise Quarter From GenMark, Adverum's Positive Gene Therapy Readout"
2020-05-04,Adverum Biotechnologies Reports Positive Interim Data from Cohorts 1-3 of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD
2020-05-04,Goldman Sachs: These 3 Stocks Are Poised to Surge by at Least 30% (NEWS-PORTAL)
2020-05-03,Goldman Sachs: These 3 Stocks Are Poised to Surge by at Least 30%
2020-04-30,Adverum Biotechnologies Announces Virtual Presentations of Data through ASGCT and ARVO
2020-04-28,Here's Why Momentum Investors Will Love Adverum Biotechnologies (ADVM)
2020-04-28,All You Need to Know About Adverum Biotechnologies (ADVM) Rating Upgrade to Buy
2020-04-27,Adverum Biotechnologies to Host a Conference Call and Webcast to Present New Data from the OPTIC Phase 1 Trial with ADVM-022 Intravitreal Gene Therapy in Wet AMD
2020-04-27,Adverum Biotechnologies Doses First Patient in Cohort 4 of OPTIC Phase 1 Clinical Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD
2020-04-20,"Adverum Biotechnologies Appoints Ophthalmology Industry Veteran Scott Whitcup, M.D. to Board of Directors"
2020-04-01,Edited Transcript of ADVM earnings conference call or presentation 12-Mar-20 8:30pm GMT
2020-03-26,"Adverum (ADVM): Strong Industry, Solid Earnings Estimate Revisions"
2020-03-18,What Makes Adverum Biotechnologies (ADVM) a New Buy Stock
2020-03-16,"Adverum Biotechnologies, Inc. Analysts Are Cutting Their Estimates: Here's What You Need To Know"
2020-03-12,"Adverum Biotechnologies (ADVM) Reports Q4 Loss, Misses Revenue Estimates"
2020-03-12,Adverum Biotechnologies Reports Recent Business Progress and Fourth Quarter 2019 Financial Results
2020-03-12,"Adverum Biotechnologies, Inc. to Host Earnings Call"
2020-03-11,Adverum Biotechnologies Announces Data Presentations at ARVO 2020
2020-03-11,Why Earnings Season Could Be Great for Adverum (ADVM)
2020-03-05,Adverum Biotechnologies to Host a Conference Call and Webcast to Report Fourth Quarter 2019 Financial Results and Provide Corporate Update
2020-03-04,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc.  ADVM"
2020-03-03,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM"
2020-03-03,"ADVM INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Adverum Biotechnologies, Inc. and Encourages Investors to Contact the Firm"
2020-03-02,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM"
2020-02-26,"SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Adverum Biotechnologies, Inc. and Encourages Investors with Losses to Contact the Firm"
2020-02-26,"ADVM INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Adverum Biotechnologies, Inc."
2020-02-26,Earnings Preview: Adverum Biotechnologies (ADVM) Q4 Earnings Expected to Decline
2020-02-26,"INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Adverum Biotechnologies, Inc. and Encourages Investors with Losses to Contact the Firm"
2020-02-25,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM"
2020-02-25,"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Adverum Biotechnologies, Inc. and Encourages Investors with Losses to Contact the Firm"
2020-02-25,"ADVM INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Adverum Biotechnologies, Inc."
2020-02-25,Adverum Biotechnologies Appoints Angela Thedinga as Chief Technology Officer
2020-02-24,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM"
2020-02-24,"ADVM INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Adverum Biotechnologies, Inc."
2020-02-19,Adverum Biotechnologies to Present at Upcoming Investor Conferences
2020-02-17,3 Stocks That Are Way More Expensive Than Tesla
2020-02-17,"Trade Alert: The Independent Director Of Adverum Biotechnologies, Inc. (NASDAQ:ADVM), James Scopa, Has Just Spent US$138k Buying Shares"
2020-02-15,Adverum (ADVM) Alert: Johnson Fistel Launches Investigation into Adverum Biotechnologies; Investors Encouraged to Contact Firm
2020-02-14,Adverum Biotechnologies Announces Closing of $150 Million Public Offering of Common Stock
2020-02-11,Adverum Biotechnologies Announces Pricing of Public Offering of Common Stock
2020-02-10,Adverum Biotechnologies Announces $100 Million Public Offering of Common Stock
2020-02-08,"Adverum Biotechnologies Reports New Interim Data from Cohorts 1 and 2 of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at Angiogenesis, Exudation, and Degeneration 2020"
2020-02-02,"The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus"
2020-01-31,We're Not Very Worried About Adverum Biotechnologies's (NASDAQ:ADVM) Cash Burn Rate
2020-01-28,"Adverum Biotechnologies to Present Additional Data from the OPTIC Phase 1 Trial with ADVM-022 Intravitreal Gene Therapy in Wet AMD at the Angiogenesis, Exudation, and Degeneration 2020 Meeting"
2020-01-27,"Adverum Biotechnologies Moves to New Headquarters and Expands Laboratory Space in Redwood City, CA"
2020-01-27,"The Market Timing Secrets No One Talks About - January 27, 2020"
2020-01-12,Adverum Biotechnologies Reports Continued Momentum with OPTIC Trial for ADVM-022 Intravitreal Gene Therapy in Wet AMD and Provides 2020 Outlook
2020-01-07,"Simple Market Timing Strategies That Work - January 07, 2020"
2019-12-18,Adverum Biotechnologies to Present at Upcoming Conferences
2019-12-14,"Hedge Funds Dropped The Ball On Adverum Biotechnologies, Inc. (ADVM)"
2019-12-02,"Shareholder Alert - Adverum Biotechnologies - Kehoe Law Firm, P.C. Investigating Potential Securities Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM"
